2024
The convergent model of coagulation. (Journal article)
Yong, J., & Toh, C. -H. (2024). The convergent model of coagulation.. Journal of thrombosis and haemostasis : JTH, S1538-7836(24)00297-6. doi:10.1016/j.jtha.2024.05.014DOI: 10.1016/j.jtha.2024.05.014
Fibrinogen binding to histones in circulation protects against adverse cellular and clinical outcomes. (Journal article)
Toh, J. M., Yong, J., Abrams, S. T., Wang, L., Schofield, J., Lane, S., . . . Toh, C. -H. (2024). Fibrinogen binding to histones in circulation protects against adverse cellular and clinical outcomes.. Journal of thrombosis and haemostasis : JTH, S1538-7836(24)00292-7. doi:10.1016/j.jtha.2024.05.009DOI: 10.1016/j.jtha.2024.05.009
2023
Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation. (Journal article)
Yong, J., & Toh, C. -H. (2023). Rethinking coagulation: from enzymatic cascade and cell-based reactions to a convergent model involving innate immune activation.. Blood, 142(25), 2133-2145. doi:10.1182/blood.2023021166DOI: 10.1182/blood.2023021166
Yong, J., Abrams, S. T., Wang, G., & Toh, C. -H. (2023). Cell-free histones and the cell-based model of coagulation.. Journal of thrombosis and haemostasis : JTH, S1538-7836(23)00340-9. doi:10.1016/j.jtha.2023.04.018DOI: 10.1016/j.jtha.2023.04.018
2022
Abrams, S. T. T., Wang, L., Yong, J., Yu, Q., Du, M., Alhamdi, Y., . . . Wang, G. (2022). The Importance of Pore-Forming Toxins in Multiple Organ Injury and Dysfunction. BIOMEDICINES, 10(12). doi:10.3390/biomedicines10123256DOI: 10.3390/biomedicines10123256
Anti-AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia (Journal article)
Yong, J., Johnstone, M., Callaghan, T., Chandrasekar, A., & Pervaiz, M. S. (2022). Anti-AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia. TRANSFUSION MEDICINE, 32(4), 346-348. doi:10.1111/tme.12884DOI: 10.1111/tme.12884
2021
Yong, J., Schofield, J., Lawton, D., & Brearton, G. (2021). CD56 positive central nervous system plasmacytosis in a patient with refractory CD56 negative primary plasma cell leukaemia.. EJHaem, 2(4), 871-872. doi:10.1002/jha2.271DOI: 10.1002/jha2.271
Dutt, T., Shaw, R. J., Stubbs, M., Yong, J., Bailiff, B., Cranfield, T., . . . Scully, M. (2021). Real-world experience with caplacizumab in the management of acute TTP. BLOOD, 137(13), 1731-1740. doi:10.1182/blood.2020007599DOI: 10.1182/blood.2020007599
Adler, H., Cruise, J., Yong, J., Patel, A., Mikhail, M., Beadsworth, M. B. J., & Beeching, N. J. (2021). Answer to March 2021 Photo Quiz.. Journal of clinical microbiology, 59(3), e00119-e00120. doi:10.1128/jcm.00119-20DOI: 10.1128/jcm.00119-20
Photo Quiz: Disseminated Violaceous Skin Lesions following Allogeneic Stem Cell Transplant (Journal article)
Adler, H., Cruise, J., Yong, J., Patel, A., Mikhail, M., Beadsworth, M. B. J., & Beeching, N. J. (2021). Photo Quiz: Disseminated Violaceous Skin Lesions following Allogeneic Stem Cell Transplant. JOURNAL OF CLINICAL MICROBIOLOGY, 59(3). doi:10.1128/JCM.00118-20DOI: 10.1128/JCM.00118-20
2020
Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report (Journal article)
Forryan, J., & Yong, J. (2020). Rapid cognitive decline in a patient with chronic lymphocytic leukaemia: a case report. JOURNAL OF MEDICAL CASE REPORTS, 14(1). doi:10.1186/s13256-020-2360-9DOI: 10.1186/s13256-020-2360-9
2019
Elimination of Acute GvHD with Three Doses of Abatacept Prophylaxis Combined with Post-Transplant Cyclophosphamide after Myeloablative Treosulfan-Based Conditioning in the HLA Identical Sibling and Unrelated (10-12/12) Peripheral Blood Stem Cell Donor Setting: Improved Safety and Efficacy Compared to Alemtuzumab Prophylaxis (Conference Paper)
Patel, A., & Yong, J. (2019). Elimination of Acute GvHD with Three Doses of Abatacept Prophylaxis Combined with Post-Transplant Cyclophosphamide after Myeloablative Treosulfan-Based Conditioning in the HLA Identical Sibling and Unrelated (10-12/12) Peripheral Blood Stem Cell Donor Setting: Improved Safety and Efficacy Compared to Alemtuzumab Prophylaxis. In BLOOD Vol. 134. doi:10.1182/blood-2019-130184DOI: 10.1182/blood-2019-130184
2018
Yong, J., Frost, F., Nazareth, D., & Walshaw, M. (2018). Case Report: Haemolytic anaemia with ceftazidime use in a patient with cystic fibrosis.. F1000Research, 7, 475. doi:10.12688/f1000research.14505.1DOI: 10.12688/f1000research.14505.1